Ignite Creation Date:
2025-12-25 @ 12:17 AM
Ignite Modification Date:
2026-02-24 @ 5:50 AM
Study NCT ID:
NCT06574958
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-08-28
First Post:
2024-08-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study of CD38\CS1 Chimeric Antigen Receptor T Cells in the Treatment of Refractory/Recurrent Multiple Myeloma
Sponsor:
The Second Hospital of Shandong University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2024 CD38/CS1 T cell of MM
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None